Inventor · disambiguated record
Dallas L. Clouatre
Also filed as: CLOUATRE DALLAS · CLOUATRE DALLAS L · CLOUATRE DALLAS LAVOE
18 granted patents·19 pending applications·195 citations·filing 2000–2022
93Inventor score
Top patents by PatentIndex Score
37 records- 0193US6207714B1Methods and pharmaceutical preparations for improving glucose metabolism with (−)-hydroxycitric acidFiled 2000·Granted Mar 27, 2001·51 cites·12 claims
- 0290US6476071B1Correcting polymorphic metabolic dysfunction with (−)-hydroxycitric acidFiled 2001·Granted Nov 5, 2002·34 cites·30 claims
- 0389US6482858B1(−)-hydroxycitric acid for wound healing and immunomodulationFiled 2001·Granted Nov 19, 2002·31 cites·12 claims
- 0489US6447807B1Potassium (-)-hydroxycitric acid methods for pharmaceutical preparations for stable and controlled deliveryFiled 2000·Granted Sep 10, 2002·32 cites·12 claims
- 0587US6441041B1(-)-hydroxycitric acid for the prevention of osteoporosisFiled 2001·Granted Aug 27, 2002·23 cites·6 claims
- 0683US10376483B2Bolus dose of hydroxycitric acid with glycerolGLYKON TECH GROUP LLC·Filed 2018·Granted Aug 13, 2019·1 cites·12 claims
- 0781US10561630B2Hydroxycitric acid compounds and capsule liquid deliveryGLYKON TECH GROUP LLC·Filed 2017·Granted Feb 18, 2020·1 cites·6 claims
- 0879US7015250B2Methods and pharmaceutical preparations for normalizing blood pressure with (-)-hydroxycitric acidGLYKON TECHNOLOGIES GROUP LLC·Filed 2001·Granted Mar 21, 2006·10 cites·18 claims
- 0975US9789076B2Bolus dose of hydroxycitric acid with glycerolGLYKON TECH GROUP LLC·Filed 2015·Granted Oct 17, 2017·1 cites·3 claims
- 1075US7189416B2Method for stable and controlled delivery of (-)-hydroxycitric acidGLYKON TECHNOLOGIES GROUP LLC·Filed 2002·Granted Mar 13, 2007·6 cites·15 claims
- 1174US10624868B2Bolus dose of hydroxycitric acid with glycerolGLYKON TECH GROUP LLC·Filed 2019·Granted Apr 21, 2020·0 cites·5 claims
- 1270US11219610B2Bolus dose of hydroxycitric acid with glycerolGLYKON TECH GROUP LLC·Filed 2020·Granted Jan 11, 2022·0 cites·5 claims
- 1369US10006079B2Method for establishing the anti-diabetic potential of bitter melonCLOUATRE DALLAS L·Filed 2014·Granted Jun 26, 2018·1 cites·5 claims
- 1468US11795187B2Hydroxycitric acid metal heterocyclic compounds with covalent characteristicsGLYKON TECH GROUP LLC·Filed 2022·Granted Oct 24, 2023·0 cites·19 claims
- 1568US9993448B2Bolus dose of hydroxycitric acid with glycerolGLYKON TECH GROUP LLC·Filed 2017·Granted Jun 12, 2018·0 cites·2 claims
- 1667US8394856B2(-)-Hydroxycitric acid for controlling inflammationCLOUATRE DALLAS L·Filed 2003·Granted Mar 12, 2013·4 cites·6 claims
- 1767US2010273884A1Method for stable and controlled delivery of (-)-hydroxycitric acidGLYKON TECHNOLOGIES GROUP LLC·Filed 2009·Application pending·0 cites
- 1865US11066423B2Monomeric bimetal hydroxycitric acid compounds and methods of making and using the sameGLYKON TECH GROUP LLC·Filed 2020·Granted Jul 20, 2021·0 cites·18 claims
- 1962US11292759B2Hydroxycitric acid metal heterocyclic compounds with covalent characteristicsGLYKON TECH GROUP LLC·Filed 2019·Granted Apr 5, 2022·0 cites·10 claims
- 2061US2010323031A1Synergistic combination to enhance blood glucose and insulin metabolismGLYKON TECHNOLOGIES GROUP LLC·Filed 2009·Application pending·0 cites
- 2161US2011105600A1Synergistic composition of (-)-hydroxycitric acid with monoterpene and a method to enhance satietyGLYKON TECHNOLOGIES GROUP LLC·Filed 2009·Application pending·0 cites
- 2258US2020138767A1Hydroxycitric acid compounds and capsule liquid deliveryGLYKON TECH GROUP LLC·Filed 2020·Application pending·0 cites
- 2357US2008293815A1Hca for improved hdl serum lipids profileGLYKON TECHNOLOGIES GROUP LLC·Filed 2007·Application pending·0 cites
- 2457US2019175610A1Formulation of galantamine and carnitine and method of fatty acid mobilizationGLYKON TECH GROUP LLC·Filed 2018·Application pending·0 cites
- 2555US2013028969A1Method for stable and controlled delivery of (-)-hydroxycitric acidGLYKON TECHNOLOGIES GROUP LLC·Filed 2012·Application pending·0 cites
- 2655US2006141030A1Method and composition for stable and controlled delivery of (-)-hydroxycitric acidCLOUATRE DALLAS L·Filed 2005·Application pending·0 cites
- 2755US2018065992A1Monomeric bimetal hydroxycitric acid compounds and methods of making and using the sameGLYKON TECH GROUP LLC·Filed 2017·Application pending·0 cites
- 2855US2012329876A1Method and composition for stable and controlled delivery of (-)-hydroxycitric acidCLOUATRE DALLAS L·Filed 2012·Application pending·0 cites
- 2953US2016108456A1Method for establishing the anti-diabetic potential of bitter melonGLYKON TECHNOLOGIES GROUP LLC·Filed 2015·Application pending·0 cites
- 3052US2005009919A1Treating cachexia and excessive catabolism with (-)-hydroxycitric acidFiled 2003·Application pending·0 cites
- 3151US2006228412A1(-)-Hydroxycitric acid for delaying gastric emptyingCLOUATRE DALLAS L·Filed 2006·Application pending·0 cites
- 3250US2007160695A1Pharmaceutical preparations for treating hypertension and dyslipidemia with Allium ursinum and Allium sativumCLOUATRE DALLAS L·Filed 2006·Application pending·0 cites
- 3350US2007184040A1Compositions for delivery of coenzyme Q10CLOUATRE DALLAS L·Filed 2006·Application pending·0 cites
- 3449US2009163580A1Anti-aging composition containing resveratrol and method of administrationNATROL INC·Filed 2008·Application pending·0 cites
- 3548US2006025482A1(-)-Hydroxycitric acid for the modulation of angiotensin-converting enzymeCLOUATRE DALLAS L·Filed 2005·Application pending·0 cites
- 3648US2006025483A1(-)-Hydroxycitric acid for protection against soft tissue and arterial calcificationCLOUATRE DALLAS L·Filed 2005·Application pending·0 cites
- 3741US2006292216A1Enteric delivery of (-)-hydroxycitric acidCLOUATRE DALLAS L·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dallas L. Clouatre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →